Jornal Vascular Brasileiro
https://jvascbras.org/article/doi/10.1590/1677-5449.210013
Jornal Vascular Brasileiro
Therapeutic Challenge

Trombose de veia porta não associada à cirrose – desafio terapêutico

Non-cirrhotic portal vein thrombosis – therapeutic challenge

Lucas Mansano Sarquis; Paula de Oliveira Trintinalha; Wilson Michaelis; Antonio Lacerda Santos Filho; Rogerio Akira Yokoyama; Thiago Michaelis; Adriana Pires Smaniotto; Mariana Santos Oliveira

Downloads: 2
Views: 1003

Resumo

Resumo: A trombose de veia porta (TVP) é uma doença na qual ocorre trombose desde os ramos intra-hepáticos da veia porta, podendo se estender até a veia esplênica e/ou veia mesentérica superior, estando associada, na maioria das vezes, à cirrose hepática. A TVP não associada a cirrose é rara. O objetivo deste artigo foi relatar dois casos de TVP não associados à cirrose, que foram tratados com anticoagulação e tiveram evolução clínica satisfatória.

Palavras-chave

embolia e trombose, trombose venosa mesentérica, anticoagulantes

Abstract

Portal vein thrombosis (PVT) is a disease in which thrombosis occurs from the intrahepatic branches of the portal vein, and may extend to the splenic vein and/or superior mesenteric vein. It is most often associated with liver cirrhosis. PVT not associated with cirrhosis is rare. The aim of this article is to report two cases of PVT in which it was not associated with cirrhosis. Both were treated with anticoagulation and clinical progress afterwards was good.

Keywords

embolism and thrombosis; mesenteric vein thrombosis; anticoagulants.

References

1 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5(1):22-40. http://dx.doi.org/10.1016/j.jceh.2014.12.008. PMid:25941431.

2 Qi X. Portal vein thrombosis: recent advance. Adv Exp Med Biol. 2017;906:229-39. http://dx.doi.org/10.1007/5584_2016_118. PMid:27638623.

3 Hanafy AS, Abd-Elsalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol. 2019;113:86-91. http://dx.doi.org/10.1016/j.vph.2018.05.002. PMid:29886103.

4 Salembier A, Verhamme M, Verhamme P, Van Moerkercke W. Acute non-cirrhotic portal vein thrombosis: review. Acta Gastroenterol Belg. 2018;81(2):318-22. PMid:30024704.

5 Sabol TP, Molina M, Wu GY. Thrombotic venous diseases of the liver. J Clin Transl Hepatol. 2015;3(3):189-94. http://dx.doi.org/10.14218/JCTH.2015.00014. PMid:26623265.

6 Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: when to treat and how? Vasc Med. 2016;21(1):61-9. http://dx.doi.org/10.1177/1358863X15611224. PMid:26584887.

7 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology. 2019;156(6):1582-99.e1. http://dx.doi.org/10.1053/j.gastro.2019.01.265. PMid:30771355.

8 Turon F, Hernández-Gea V, García-Pagán JC. Portal vein thrombosis: yes or no on anticoagulation therapy. Curr Opin Organ Transplant. 2018;23(2):250-6. http://dx.doi.org/10.1097/MOT.0000000000000506. PMid:29432256.

9 Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ. Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis. Int J Hepatol. 2018;2018:8432781. http://dx.doi.org/10.1155/2018/8432781. PMid:29973997.

10 Ghazaleh S, Beran A, Aburayyan K, et al. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis. Ann Gastroenterol. 2021;34(1):104-10. PMid:33414629.

11 Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis. Gastroenterology. 2017;153(2):480-487.e1. http://dx.doi.org/10.1053/j.gastro.2017.04.042.

12 Mohan BP, Aravamudan VM, Khan SR, Ponnada S, Asokkumar R, Adler DG. Treatment response and bleeding events associated with anticoagulant therapy of portal vein thrombosis in cirrhotic patients: systematic review and meta-analysis. Ann Gastroenterol. 2020;33(5):521-7. http://dx.doi.org/10.20524/aog.2020.0503. PMid:32879600.

13 Shatzel JJ, O’Donnell M, Olson SR, et al. Venous thrombosis in unusual sites: a practical review for the hematologist. Eur J Haematol. 2019;102(1):53-62. http://dx.doi.org/10.1111/ejh.13177. PMid:30267448.

14 Vianna R, Beduschi T. Multivisceral transplantation for diffuse splanchnic venous thrombosis. Curr Opin Organ Transplant. 2016;21(2):201-8. http://dx.doi.org/10.1097/MOT.0000000000000298. PMid:26867050.
 


Submitted date:
01/16/2021

Accepted date:
12/01/2021

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
6241c2dca953956d267782a2 jvb Articles

J Vasc Bras

Share this page
Page Sections